Retinal Organoid Technology: Where Are We Now?

Int J Mol Sci. 2021 Sep 23;22(19):10244. doi: 10.3390/ijms221910244.

Abstract

It is difficult to regenerate mammalian retinal cells once the adult retina is damaged, and current clinical approaches to retinal damages are very limited. The introduction of the retinal organoid technique empowers researchers to study the molecular mechanisms controlling retinal development, explore the pathogenesis of retinal diseases, develop novel treatment options, and pursue cell/tissue transplantation under a certain genetic background. Here, we revisit the historical background of retinal organoid technology, categorize current methods of organoid induction, and outline the obstacles and potential solutions to next-generation retinal organoids. Meanwhile, we recapitulate recent research progress in cell/tissue transplantation to treat retinal diseases, and discuss the pros and cons of transplanting single-cell suspension versus retinal organoid sheet for cell therapies.

Keywords: disease models; inner cell layer degeneration; retinal development; retinal organoid; stem cells; transplantation.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Organoids / cytology*
  • Retina / cytology*
  • Retinal Diseases / therapy
  • Tissue Transplantation / methods*